Feasibility of high intensity interval training in patients with breast Cancer undergoing anthracycline chemotherapy: a randomized pilot trial

Kyuwan Lee, Irene Kang, Wendy J Mack, Joanne Mortimer, Fred Sattler, George Salem, Christina M Dieli-Conwright, Kyuwan Lee, Irene Kang, Wendy J Mack, Joanne Mortimer, Fred Sattler, George Salem, Christina M Dieli-Conwright

Abstract

Background: Anthracycline-based chemotherapy is associated with reduced cardiorespiratory fitness in breast cancer patients. High intensity interval training (HIIT) induces greater benefits on cardiorespiratory fitness than moderate continuous aerobic exercise in patients with heart failure. The study purpose was to determine whether a HIIT intervention is a feasible exercise strategy for breast cancer patients undergoing anthracycline-based chemotherapy.

Methods: Thirty women were randomized to either HIIT or non-exercise control group (CON). Participants performed a maximal cycling fitness test to measure peak power output during maximal oxygen uptake (VO2max). The HIIT group participated in an 8-week HIIT intervention occurring 3 times weekly. Feasibility was calculated by computing (1) the average weekly minutes of HIIT over 8 weeks and (2) the number of sessions attended and multiplied by 100 (percentage of sessions). The intervention was considered feasible if more than 50% of participants completed both an average of 70% of weekly minutes (63/90 min) and attended 70% exercise sessions (17/24 sessions).

Results: Participants were 46.9 ± 9.8 (mean ± SD) years old, diagnosed with clinical stage II (30%) or III (63%) breast cancer. The average weekly minutes of exercise completed was 78 ± 5.1 out of 90 min. Twelve of 15 participants met both feasibility criteria, attending 19.2 ± 2.1 out of 24 sessions (82.3%). VO2max was maintained (19.7 ± 8.7 to 19.4 ± 6.6 ml/kg/min) in HIIT group (p = 0.94) while there was a significant decrease in VO2max (18.7 ± 7.1 to 16.1 ± 6.0 ml/kg/min) in CON group from baseline to 8 weeks (p = 0.001).

Conclusions: HIIT is a feasible exercise intervention to maintain VO2max in breast cancer patients receiving anthracycline-based chemotherapy.

Trial registration: The protocol and informed consent were approved by the institutional IRB (HS-12-00227) and registered ( ClinicalTrials.gov NCT02454777; date of registration: May 272,015).

Keywords: Anthracycline; Breast cancer; Feasibility; High intensity interval training; Peak power output.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
CONSORT diagram of HIIT intervention. HIIT, high intensity interval training; CON, delayed; USC, University of Southern California; NCCC, Norris Comprehensive Cancer Center; LAC, Los Angeles County
Fig. 2
Fig. 2
Box plot for VO2max at baseline and 8 week post-treatment in the HIIT group and the CON group

References

    1. Gradishar WJ, Anderson BO, Balassanian R, Blair SL, Burstein HJ, et al. Breast Cancer, version 4.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2018;16:310–320. doi: 10.6004/jnccn.2018.0012.
    1. Boekel N, Jacobse J, Schaapveld M, Gietema J, Hooning M, et al. Long-term risks of specific cardiovascular diseases associated with contemporary breast cancer treatment in combination with cardiovascular risk factors: a large Dutch cohort study. Eur J Cancer. 2016;57:S142.
    1. Bernhorster M, Lungwitz A, Rosenhagen A, Vogt L, Jager E, et al. Exercise training during chemotherapy treatment enhances quality of life and aerobic capacity. Onkologie. 2008;31:170–171.
    1. Goldstein D, Bennett BK, Webber K, Boyle F, de Souza PL, et al. Cancer-related fatigue in women with breast cancer: outcomes of a 5-year prospective cohort study. J Clin Oncol. 2012;30:1805–1812. doi: 10.1200/JCO.2011.34.6148.
    1. Shachar SS, Deal AM, Mitin N, Nyrop KA, Lee JT, et al. Changes in p16INK4a (p16) expression, a biomarker of aging, in peripheral blood T-cells (PBTC) in patients receiving anthracycline (a) vs non-anthracycline (NoA) chemotherapy (CRx) for early-stage breast cancer (EBC). J Clin Oncol. 2017;35.
    1. Pearson EJ, Nair A, Daoud Y, Blum JL. The incidence of cardiomyopathy in BRCA1 and BRCA2 mutation carriers after anthracycline-based adjuvant chemotherapy. Breast Cancer Res Treat. 2017;162:59–67. doi: 10.1007/s10549-016-4101-8.
    1. Fraser Steve, Bigaran Ashley, Selig Steve, LaGerche Andre. Exercise training during anthracycline-based chemotherapy for breast cancer. Journal of Clinical Oncology. 2017;35(15_suppl):e12110–e12110. doi: 10.1200/JCO.2017.35.15_suppl.e12110.
    1. Parry TL, Hayward R. Exercise training does not affect anthracycline antitumor efficacy while attenuating cardiac dysfunction. Am J Phys Regul Integr Comp Phys. 2015;309:R675–R683.
    1. Jones LW, Fels DR, West M, Allen JD, Broadwater G, et al. Modulation of circulating Angiogenic factors and tumor biology by aerobic training in breast Cancer patients receiving neoadjuvant chemotherapy. Cancer Prev Res. 2013;6:925–937. doi: 10.1158/1940-6207.CAPR-12-0416.
    1. Courneya KS, Segal RJ, Mackey JR, Gelmon K, Reid RD, et al. Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. J Clin Oncol. 2007;25:4396–4404. doi: 10.1200/JCO.2006.08.2024.
    1. Courneya KS, Segal RJ, McKenzie DC, Dong H, Gelmon K, et al. Effects of exercise during adjuvant chemotherapy on clinical outcomes in early stage breast cancer. Cancer Res. 2013;73.
    1. Ellingsen O, Halle M, Conraads V, Stoylen A, Dalen H, et al. High-intensity interval training in patients with heart failure with reduced ejection fraction. Circulation. 2017;135:839–849. doi: 10.1161/CIRCULATIONAHA.116.022924.
    1. Boyne P, Dunning K, Carl D, Khoury JC, Gerson M, et al. High intensity interval training may be superior to moderate intensity continuous exercise in chronic stroke. Stroke. 2015;46.
    1. Sawyer BJ, Bhammar DM, Tucker WJ, Gaesser GA. Effects of high-intensity interval and continuous training on endothelial function and glucose regulation in obesity. Med Sci Sports Exerc. 2014;46:863. doi: 10.1249/01.mss.0000496088.41338.4e.
    1. Pimenta M, Bringhenti I, Souza-Mello V, Mendes LKD, Aguila MB, et al. High-intensity interval training beneficial effects on body mass, blood pressure, and oxidative stress in diet-induced obesity in ovariectomized mice. Life Sci. 2015;139:75–82. doi: 10.1016/j.lfs.2015.08.004.
    1. Larsen AI, Valborgland T, Vegsundvag J, Isaksen K, Skadberg M, et al. Aerobic high-intensity exercise training improves coronary flow reserve velocity and endothelial function in individuals with chest pain and normal coronary angiogram. Eur Heart J. 2015;36:1154. doi: 10.1093/eurheartj/ehu512.
    1. Mijwel S, Backman M, Bolam KA, Jervaeus A, Sundberg CJ, et al. Adding high-intensity interval training to conventional training modalities: optimizing health-related outcomes during chemotherapy for breast cancer: the OptiTrain randomized controlled trial. Breast Cancer Res Treat. 2017.
    1. Adams VV, Fischer T, Alves M, Rolim N, Werner S, et al. High intensity interval training attenuates endothelial dysfunction in heart failure with preserved ejection fraction (HFpEF) Eur J Heart Fail. 2015;17:355. doi: 10.1002/ejhf.261.
    1. Turk Y, Theel W, Kasteleyn MJ, Franssen FME, Hiemstra PS, et al. High intensity training in obesity: a meta-analysis. Obes Sci Pract. 2017;3:258–271. doi: 10.1002/osp4.109.
    1. Currie KD, McKelvie RS, MacDonald MJ. Flow-mediated dilation is acutely improved after high-intensity interval exercise. Med Sci Sports Exerc. 2012;44:2057–2064. doi: 10.1249/MSS.0b013e318260ff92.
    1. Patterson RP, Moreno MI. Bicycle pedaling forces as a function of pedaling rate and power output. Med Sci Sports Exerc. 1990;22:512–516. doi: 10.1249/00005768-199008000-00016.
    1. Currie KD, Bailey KJ, Jung ME, McKelvie RS, MacDonald MJ. Effects of resistance training combined with moderate-intensity endurance or low-volume high-intensity interval exercise on cardiovascular risk factors in patients with coronary artery disease. J Sci Med Sport. 2015;18:637–642. doi: 10.1016/j.jsams.2014.09.013.
    1. Cockcroft EJ, Williams CA, Tomlinson OW, Vlachopoulos D, Jackman SR, et al. High intensity interval exercise is an effective alternative to moderate intensity exercise for improving glucose tolerance and insulin sensitivity in adolescent boys. J Sci Med Sport. 2015;18:720–724. doi: 10.1016/j.jsams.2014.10.001.
    1. Lee K, Kang I, Mortimer JE, Sattler F, Mack WJ, et al. Effects of high-intensity interval training on vascular function in breast cancer survivors undergoing anthracycline chemotherapy: design of a pilot study. BMJ Open. 2018;8:e022622.
    1. Takaishi T, Yasuda Y, Ono T, Moritani T. Optimal pedaling rate estimated from neuromuscular fatigue for cyclists. Med Sci Sports Exerc. 1996;28:1492–1497. doi: 10.1097/00005768-199612000-00008.
    1. Ahlquist LE, Bassett DR, Sufit R, Nagle FJ, Thomas DP. The effect of pedaling frequency on glycogen depletion rates in type-I and type-ii quadriceps muscle-fibers during submaximal cycling exercise. Eur J Appl Physiol Occup Physiol. 1992;65:360–364. doi: 10.1007/BF00868141.
    1. Courneya KS, McKenzie DC, Mackey JR, Gelmon K, Friedenreich CM, et al. Effects of exercise dose and type during breast Cancer chemotherapy: multicenter randomized trial. J Natl Cancer Inst. 2013;105:1821–1832. doi: 10.1093/jnci/djt297.
    1. De Jesus S, Fitzgeorge L, Unsworth K, Massel D, Suskin N, et al. Feasibility of an exercise intervention for fatigued breast cancer patients at a community-based cardiac rehabilitation program. Cancer Manag Res. 2017;9:29–39. doi: 10.2147/CMAR.S117703.
    1. Blanchard CM, Courneya KS, Stein K. Cancer survivors' adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society's SCS-II. J Clin Oncol. 2008;26:2198–2204. doi: 10.1200/JCO.2007.14.6217.
    1. Kim Y, Park I, Kang M. Convergent validity of the international physical activity questionnaire (IPAQ): meta-analysis. Public Health Nutr. 2013;16:440–452. doi: 10.1017/S1368980012002996.
    1. Scholes Shaun, Bridges Sally, Ng Fat Linda, Mindell Jennifer S. Comparison of the Physical Activity and Sedentary Behaviour Assessment Questionnaire and the Short-Form International Physical Activity Questionnaire: An Analysis of Health Survey for England Data. PLOS ONE. 2016;11(3):e0151647. doi: 10.1371/journal.pone.0151647.
    1. Dieli-Conwright CM, Courneya KS, Demark-Wahnefried W, Sami N, Lee K, et al. Effects of aerobic and resistance exercise on metabolic syndrome, Sarcopenic obesity, and circulating biomarkers in overweight or obese survivors of breast Cancer: a randomized controlled trial. J Clin Oncol. 2018; JCO2017757526.
    1. Tang WW, Li ZX, Tang CY, Wang XW, Wang HJ. Health literacy and functional exercise adherence in postoperative breast cancer patients. Patient Prefer Adherence. 2017;11:781–786. doi: 10.2147/PPA.S127925.
    1. Scott JM, Nilsen TS, Gupta D, Jones LW. Exercise therapy and cardiovascular toxicity in Cancer. Circulation. 2018;137:1176–1191. doi: 10.1161/CIRCULATIONAHA.117.024671.
    1. Jones LW, Courneya KS, Mackey JR, Muss HB, Pituskin EN, et al. Cardiopulmonary function and age-related decline across the breast Cancer survivorship continuum. J Clin Oncol. 2012;30:2530–2537. doi: 10.1200/JCO.2011.39.9014.
    1. Frydenberg H, Bettum TJ, Lofterod T, Edvardsen E, Flote VG, et al. Cardiorespiratory fitness (VO2max) before, during and after adjuvant treatment in breast cancer patients. Cancer Res. 2015;75.
    1. Kirkham AA, Lloyd MG, Claydon VE, Gelmon KA, McKenzie DC, et al. A longitudinal study of the Association of Clinical Indices of cardiovascular autonomic function with breast Cancer treatment and exercise training. Oncologist. 2018.
    1. Zare N, Ghanbari S, Salehi A. Effects of two chemotherapy regimens, anthracycline-based and CMF, on breast Cancer disease free survival in the eastern Mediterranean region and Asia: a meta-analysis approach for survival curves. Asian Pac J Cancer Prev. 2013;14:2013–2017. doi: 10.7314/APJCP.2013.14.3.2013.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel